Related Articles
Correlation between salivary and serum CA15‑3 concentrations in patients with breast cancer
Determination of the prognostic value of preoperative CA15‑3 and CEA in predicting the prognosis of young patients with breast cancer
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients
Use of CA15‑3 for screening breast cancer: An antibody‑lectin sandwich assay for detecting glycosylation of CA15‑3 in sera
Binding of circulating anti-MUC1 antibody and serum MUC1 antigen in stage IV breast cancer